In vivo animal studies with sugammadex

被引：13
作者：
Booij, L. H. D. J. [1 ]
van Egmond, J. [1 ]
Driessen, J. J. [1 ]
de Boer, H. D. [2 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol, NL-6525 ED Nijmegen, Netherlands
[2] Martini Ziekenhuis, Groningen, Netherlands
来源：
ANAESTHESIA | 2009年 / 64卷
关键词：
ACETYLCHOLINESTERASE INHIBITORS; NEUROMUSCULAR BLOCKADE; REVERSAL AGENTS; ROCURONIUM BROMIDE; RESIDUAL PARALYSIS; PHARMACOKINETICS; CYCLODEXTRINS; DERIVATIVES; VECURONIUM; ORG-25969;
D O I：
10.1111/j.1365-2044.2008.05869.x
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
A review is presented of animal studies of the selective steroidal neuromuscular blocking drug binding agent sugammadex. These studies demonstrate that sugammadex is faster in onset than the currently used acetylcholinesterase inhibitors, has no muscarinic effects, and is characterised by lack of adverse effects on other organs. These results offer support for the future development of sugammadex for clinical use in humans.
引用
收藏
页码：38 / 44
页数：7
相关论文
共 35 条
  • [1] ABAJIAN J, 1955, ANN SURG, V142, P138
  • [2] Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: Synthesis and structure-activity relationships
    Adam, JM
    Bennett, DJ
    Bom, A
    Clark, JK
    Feilden, H
    Hutchinson, EJ
    Palin, R
    Prosser, A
    Rees, DC
    Rosair, GM
    Stevenson, D
    Tarver, GJ
    Zhang, MQ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1806 - 1816
  • [3] A STUDY OF THE DEATHS ASSOCIATED WITH ANESTHESIA AND SURGERY - BASED ON A STUDY OF 599,548 ANESTHESIAS IN 10 INSTITUTIONS 1948-1952, INCLUSIVE
    BEECHER, HK
    TODD, DP
    [J]. ANNALS OF SURGERY, 1954, 140 (01) : 2 - 34
  • [4] Residual neuromuscular block is a risk factor for postoperative pulmonary complications - A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
    Berg, H
    VibyMogensen, J
    Roed, J
    Mortensen, CR
    Engbaek, J
    Skovgaard, LT
    Krintel, JJ
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1997, 41 (09) : 1095 - 1103
  • [5] Bom A, 2002, ANGEW CHEM INT EDIT, V41, P266
  • [6] BOM A, 2006, CURRENT OPINION PHAR, V7, P298
  • [7] BOM AH, 2002, ANESTHESIOLOGY, V96, pA1009
  • [8] Non-depolarizing neuromuscular blocking activity of bisquaternary amino di- and tripeptide derivatives
    Booij, LHDJ
    van der Broek, LAGM
    Caulfield, W
    Dommerholt-Caris, BMG
    Clark, JK
    van Egmond, J
    McGuire, R
    Muir, AW
    Ottenheijm, HCJ
    Rees, DC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) : 4822 - 4833
  • [9] Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: New ultra-short-acting nondepolarizing neuromuscular blockers
    Boros, EE
    Bigham, EC
    Boswell, GE
    Mook, RA
    Patel, SS
    Savarese, JJ
    Ray, JA
    Thompson, JB
    Hashim, MA
    Wisowaty, JC
    Feldman, PL
    Samano, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) : 206 - 209
  • [10] Anionic cyclophanes as potential reversal agents of muscle relaxants by chemical chelation
    Cameron, KS
    Fielding, L
    Mason, R
    Muir, AW
    Rees, DC
    Thorn, S
    Zhang, MQ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) : 753 - 755
1234